Kadimastem Finishes Treating Second Group of ALS Patients with AstroRx in Phase 1/2a Trial
Kadimastem has finished treating its second group of participants in a Phase 1/2a clinical trial testing…
Alejandra has a PhD in Genetics from São Paulo State University (UNESP) and is currently working as a scientific writer, editor, and translator. As a writer for BioNews, she is fulfilling her passion for making scientific data easily available and understandable to the general public. Aside from her work with BioNews, she also works as a language editor for non-English speaking authors and is an author of science books for kids.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Kadimastem has finished treating its second group of participants in a Phase 1/2a clinical trial testing…
Aquestive Therapeutics has granted a development and commercialization license to Zambon Pharma for its investigational oral…
Aural Analytics and the Translational Genomics Research Institute (TGen) will collaborate on…
Radicava (edaravone), an intravenous treatment for amyotrophic lateral sclerosis (ALS), is now commercially available in Canada, Mitsubishi Tanabe…
AcuraStem has triggered $3 million in Phase 2 funding from its Small…
High glucose levels might compensate for the toxic effects of an accumulation of TDP-43 — a widely expressed…
AB Science has optimized the design of a Phase 3 confirmatory study for mastinib, its oral treatment for amyotrophic…
A potential therapy for amyotrophic lateral sclerosis (ALS) consisting of an antibody that reduces the abnormal accumulation of the TDP-43 protein improved…
A human-derived antibody that specifically binds to abnormal superoxide dismutase 1 (SOD1) improved the symptoms and delayed disease progression in…
In addition to symptoms of depression, disease progression is one of the strongest influences on health-related quality of life in…